Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Pegnaloxol -- a potential treatment for opioid-induced bowel dysfunction

Sep. 19, 2007

Preclinical data on potential targets for the development of agents for sleep disorders

Sep. 19, 2007

Retreatment with Tookad phototherapy feasible and active in prostate cancer

Sep. 19, 2007

Recent data on triple angiokinase inhibitor BIBF-1120 in NSCLC presented

Sep. 19, 2007

XL-647 demonstrates antitumor activity in non-small cell lung cancer patients

Sep. 19, 2007

Initial phase I results show IMO-2055 plus chemotherapy feasible for solid tumors

Sep. 19, 2007

BLI-489 shows in vitro and in vivo efficacy in combination with piperacillin

Sep. 18, 2007

LK-157: a broad spectrum beta-lactamase inhibitor presented at ICAAC

Sep. 18, 2007

KBPA-101: suitable clinical candidate to treat ventilator-associated P. aeruginosa infections

Sep. 18, 2007

Novel candidate for hepatitis C therapy: IMO-2125

Sep. 18, 2007

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...